Back to Top

Aims & Scope


Re:GEN Open is a multidisciplinary open access peer-reviewed journal covering all aspects of biomedical research and regenerative medicine, as well as biotechnology.  The new peer-reviewed Journal from Mary Ann Liebert, Inc. combines the dynamic global media presence of Genetic Engineering & Biotechnology News (GEN) to deliver research providing essential information that furthers the knowledge base in the global scientific community across leading media platforms.

Re:GEN Open provides a high-profile platform for cutting-edge international original research papers, as well as a mixture of frontmatter content such as comprehensive review articles, mini-reviews, rapid communications, brief reports, protocols, and technology reports. The Journal publishes on a continuous cycle using an open access format which allows for broad visibility and the widest distribution of content.

Benefits of publishing in Re:GEN Open:

  • Open access guarantees broadest possible visibility for author’s work
  • Rapid, authoritative peer review that is trusted across the industry
  • Retain copyright of your work with a CC-BY license, the most liberal available
  • Fully funder compliant, ensuring you meet all grant requirements
  • Preprints welcome
  • Articles included in dynamic marketing campaigns to more than 100,000 engaged users
  • Select articles promoted via social media to more than 600,000 followers
  • Global media outreach for selected papers
  • Translation, editing, and research promotion services available

Re:GEN Open coverage includes:

  • Basic Biomedical Research
  • Translational Biomedical Research
  • Cell and Gene Therapy
  • Synthetic and Systems Biology
  • Regenerative Medicine
  • Drug Development
  • Cancer Research
  • Infectious Disease

Re:GEN Open is currently under the interim editorial leadership of Karen Cloud-Hansen, PhD and has assembled a diverse international Editorial Advisory Board who are experts in their fields. View the entire editorial board.

Audience: Cell, DNA, molecular, and developmental biologists, computational biologists, data scientists, biochemists, stem cell researchers, genetic engineers, geneticists, tissue engineers, cancer researchers, aging researchers, regenerative medicine researchers, hematologists, oncologists, nuclear medicine researchers, respiratory and pulmonary specialists, internal medicine specialists, radiologists, pathologists, ophthalmologists, optometrists, immunologists, virologists, microbiologists, infectious disease specialists, veterinary researchers, bacteriologists, Precision medicine scholars, bioinformaticians and computational biologists, biomedical and biomaterials engineers, among others.

Indexing/Abstracting:

  • Directory of Open Access Journals (DOAJ)
The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.